GMP

Conference Spotlight

A New Drug GMP Mutual Recognition Agreement Model

April 24, 2024

Conference Spotlight

Health Canada Remote/Virtual and Hybrid GMP Inspections – and Which Your Facility May Expect

April 11, 2024

Legal Advice for Before, During, and After an FDA Inspection

July 25, 2023

Enforcement

Expert Commentary: FY2022 Report on the State of Pharmaceutical Quality

June 29, 2023

Conference Spotlight

A Deep Dive into Cell and Gene Therapy Regulatory Considerations: Part Two

May 25, 2023

Enforcement

Internal Audit Reports: Can the FDA Take a Peek?

April 19, 2023

Conference Spotlight

Is Raw FDA Data Skewing Your Analyses?

March 23, 2023

Beyond Data Integrity: Ulrich Köllisch on Building a Culture for Tomorrow’s High-End Data Tools

March 14, 2023

Conference Spotlight

Should ICH Tackle Standard Development for CGT Products?

March 8, 2023

What Are Inferred CFR Codes?

February 24, 2023

Conference Spotlight

Post-Approval Change Management Protocol Pilot Aims to Reduce Approval Time

October 19, 2022

Why am I Being Inspected Again So Soon After a Pre-Approval Inspection?

October 6, 2022

Conference Spotlight

FDA on Compliance Issues in Pharma

September 16, 2022

Redica Responds: How Many GMP Inspections Have Resulted in a 483?

September 14, 2022

Regulatory Expectations for Cleaning Validation

August 30, 2022

Redica Responds: Insights on Media Fill Enforcement Trends

August 24, 2022

GMP Considerations for Cell and Gene Therapies

August 16, 2022

A Short Guide to GMP Process Validation

July 19, 2022

Invest in Tech to Avoid Data Integrity Issues

July 7, 2022

What is GMP Compliance? A Complete 2025 Guide

June 21, 2022

Root Cause Analysis of Medical Devices

June 8, 2022

Conference Spotlight

Perforated Tables in Cleanrooms Draw FDA Attention

June 2, 2022

Conference Spotlight

Discolored HEPA Filters Recolored by Sterile Manufacturer

May 24, 2022

Conference Spotlight

Case Study of Contaminated WFI in China

February 3, 2021

All tags